Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | CASP3 | P42574 | 3/20 | 0.46 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14787297 | 0.93 | CASP3 (0.47) | MDM4TP53CASP3FDFT1MDM2 | |
| SCHEMBL30892068 | 0.90 | PTPN1 (0.49) | MDM4TP53CASP3 | |
| SCHEMBL29722079 | 0.89 | PTPN1 (0.49) | MDM4TP53KMT2A | |
| SCHEMBL14788960 | 0.89 | MDM4 (0.46) | MDM4TP53CASP3MDM2TLR2 | |
| SCHEMBL30582698 | 0.89 | CASP3 (0.54) | MDM4TP53CASP3KMT2A | |
| SCHEMBL119497 | 0.88 | CASP3 (0.52) | MDM4TP53CASP3MDM2KMT2A | |
| SCHEMBL1564185 | 0.88 | CASP3 (0.52) | MDM4TP53CASP3MDM2KMT2A | |
| SCHEMBL1486287 | 0.88 | CASP3 (0.52) | MDM4TP53CASP3MDM2KMT2A | |
| SCHEMBL6038102 | 0.88 | CASP3 (0.52) | MDM4TP53CASP3MDM2KMT2A | |
| SCHEMBL30896048 | 0.88 | CASP3 (0.52) | MDM4TP53CASP3MDM2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9127039-B2 | Sulfur-containing amino acid derivative | AJINOMOTO CO., INC. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-9127039-B2 | Sulfur-containing amino acid derivative | AJINOMOTO CO., INC. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20130071863-A1 | Sulfur-Containing Amino Acid Derivative | AJINOMOTO CO., INC. (JP) | 2013-03-21 | — | — | US | disclosed |
| US-20130071863-A1 | Sulfur-Containing Amino Acid Derivative | AJINOMOTO CO., INC. (JP) | 2013-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071863-A1 | Sulfur-Containing Amino Acid Derivative | SLC7A5, CTH, CBS | MDM4 1996/4885TP53 3873/4885CASP3 4761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.